Embed Size (px)
DESCRIPTION
MERCK: ZONTIVITY (VORAPAXAR SULFATE) is a protease-activated receptor-1 (PAR-1) antagonist indicated for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or with peripheral arterial disease (PAD). ZONTIVITY has been shown to reduce the rate of a combined endpoint of cardiovascular death, MI, stroke, and urgent coronary revascularization. DURATA THERAPEUTICS: DALVANCE (DALBAVANCIN HYDROCHLORIDE) is indicated for acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible strains of Gram-positive microorganisms. TAKEDA PHARMS USA: ENTYVIO is an integrin receptor antagonist indicated for Adult Ulcerative Colitis (UC) and Adult Crohn's Disease (CD). New formulation or new manufacturer of EPANOVA (OMEGA 3 CARBOXYLIC ACIDS) from ASTRAZENECA,IZBA (TRAVOPROST) from ALCON LABS, and NATESTO (TESTOSTERONE) from TRIMEL BIOPHARMA were approved.
Citation preview
PharmaSages_May FDA ApprovalsMERCK: ZONTIVITY (VORAPAXAR SULFATE) is a protease-activated receptor-1 (PAR-1) antagonist indicated for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or with peripheral arterial disease (PAD). ZONTIVITY has been shown to reduce the rate of a combined endpoint of cardiovascular death, MI, stroke, and urgent coronary revascularization.
DURATA THERAPEUTICS: DALVANCE (DALBAVANCIN HYDROCHLORIDE) is indicated for acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible strains of Gram-positive microorganisms.
TAKEDA PHARMS USA: ENTYVIO is an integrin receptor antagonist indicated for Adult Ulcerative Colitis (UC) and Adult Crohn's Disease (CD).
New formulation or new manufacturer of EPANOVA (OMEGA 3 CARBOXYLIC ACIDS) from ASTRAZENECA,IZBA (TRAVOPROST) from ALCON LABS, and NATESTO (TESTOSTERONE) from TRIMEL BIOPHARMA were approved.
Contact us
Ajay Shrivastava, CEO
PharmaSages58 Magnolia Lane
Princeton, NJ 08540Phone: (609)423-7602
E-mail:[email protected]: www.pharmasages.com
